OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
How have lessons from the pandemic influenced the way companies use technology to perform quality-control procedures?
Preclinical and clinical research is improving ADC development.
Strategizing drug development in the preclinical phase has merit.
Perfusion cell culture gains advantage with PAT tools advancement.
Coating is an alternative to silicone oil as a lubricant. URL for article
Novavax COVID-19 Vaccine Receives EUA in Indonesia
January 26, 2022
Delays in sponsors providing postapproval evidence of effectiveness for therapies benefitting from streamlined FDA regulatory pathways are generating pressure for further review and reform of the agency’s accelerated approval process.
January 25, 2022
Merck and Ridgeback Therapeutics will supply UNICEF with up to three million capsules of molnupiravir through the first half of 2022.
UCB and Zogenix have agreed to an acquisition deal totaling nearly $2 billion.
January 21, 2022
A report by international regulators reviews the effectiveness of current COVID-19 vaccines against the omicron variant.
The company is voluntarily recalling one batch of Semglee prefilled pens because of a potential missing label.
Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals.
January 19, 2022
The agency discusses its response to COVID-19 and other milestones in its year-end review.
The agency’s COVID-19 task force says latest data shows use of COVID-19 mRNA vaccines during pregnancy is safe.
January 18, 2022
Samsung Biologics is planning to construct a new manufacturing facility in Incheon, South Korea, that will offer multi-product manufacturing, including cell and gene therapies and next-gen vaccines.
In their collaboration, Bristol Myers Squibb and Prellis Biologics aim to generate human antibody libraries for select targets to enable drug discovery.
After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.
January 17, 2022
CDMO Forge Biologics will accelerate its manufacturing capacity expansion using an additional $80 million in funding it recently secured.